Raymond James Financial Services Advisors, Inc. Guardant Health, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 19,294 shares of GH stock, worth $629,949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,294Holding current value
$629,949% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$382 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$367 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$331 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$226 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$196 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.34B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...